SCHEMBL6206056

SCHEMBL6206056

[CH2]c1ccc(CNCCCN2CCOCC2)cc1

nearest known ligand 0.70

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.70
CYP3A4 P08684 1/20 0.70
CYP2D6 P10635 1/20 0.70
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
POLB P06746 3/20 0.50
PARP1 P09874 1/20 0.49
MAPT P10636 1/20 0.49
KDM1A O60341 1/20 0.47
ALDH1A1 P00352 4/20 0.47
SIGMAR1 Q99720 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
TNKS2 Q9H2K2 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3175221 0.92 CYP2C19 (0.80) CYP2C19CYP3A4CYP2D6MEN1KMT2A
SCHEMBL6205018 0.91 CYP2D6 (0.57) CYP2C19CYP3A4CYP2D6MEN1KMT2A
SCHEMBL3179723 0.89 CYP2C19 (0.76) CYP2C19CYP3A4CYP2D6MEN1KMT2A
SCHEMBL3181015 0.88 CYP2C19 (0.74) CYP2C19CYP3A4CYP2D6MEN1KMT2A
SCHEMBL3997594 0.85 CYP2C19 (0.70) CYP2C19CYP3A4CYP2D6MEN1KMT2A
SCHEMBL3181193 0.85 CYP2C19 (0.70) CYP2C19CYP3A4CYP2D6MEN1KMT2A
SCHEMBL14068495 0.85 CYP2C19 (0.70) CYP2C19CYP3A4CYP2D6MEN1KMT2A
SCHEMBL3175514 0.85 CYP2C19 (0.70) CYP2C19CYP3A4CYP2D6MEN1KMT2A
SCHEMBL3173535 0.85 CYP2C19 (0.70) CYP2C19CYP3A4CYP2D6MEN1KMT2A
SCHEMBL9884549 0.85 CYP2C19 (0.70) CYP2C19CYP3A4CYP2D6MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177177-B1 SUBSTITUTED 4-OXO-QUINOLINE-3-CARBOXAMIDES: GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORP (US) 2005-02-23 EP disclosed
US-6413956-B1 AGONISTS, ANTAGONISTS OR INVERSE AGONISTS AND LOCALIZATION PROBES FOR GAMMA AMINOBUTYRIC ACID BRAIN RECEPTORS; ANXIETY, DEPRESSION, DOWN SYNDROME, SLEEP AND SEIZURE DISORDERS, OVERDOSE WITH BENZODIAZEPINE DRUGS AND MEMORY ENHANCEMENT NEUROGEN CORPORATION 2002-07-02 US disclosed